Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check35 days agoChange DetectedThe page has updated the number of study locations from 60 to 61 and added specific contact information for the principal investigator, including their name, phone number, and email address.SummaryDifference0.8%
- Check42 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check64 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check71 days agoChange DetectedThe website has updated its contact information for the Principal Investigators, removing the previous designation and adding a new contact, Vijendra Swarup, MD, while also revising the version from v2.13.3 to v2.14.0.SummaryDifference26%
Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.